NCT01348061View on ClinicalTrials.gov

Evaluating Cerebrospinal Fluid Biomarkers in Alzheimer's, Progressive Supranuclear Palsy Subjects, and Controls

CompletedOBSERVATIONAL
Enrollment

16

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Alzheimer DiseaseProgressive Supranuclear Palsy
Trial Locations (3)

78217

Worldwide Clinical Trials, San Antonio

91206

Parexel, Glendale

07724

Memory Enhancement Centers of America Inc., Eatontown

Sponsors

Lead Sponsor

KineMed

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

KineMed

INDUSTRY